VerifyRecall
Alerts
RECALL RECORD — CLASS IRecall closedF-2030-2014/FDA enforcement
Miami Interculinary Center, INC.·Food·Apr 23, 2014

Floribbean Key Lime Calypso Dip 12.5 OZ Floribbean 68 Sw 40 St

What you need to know

Class I

  • What happened

    During an FDA inspection a product was found that the label fail to declared the component ingredients of all its compound ingredients like Mayonnaise and Worcestershire sauce…

  • Health risk

    The product has a reasonable probability of causing serious adverse health consequences or death. An allergen that is present but missing or incorrect on the label can cause a serious reaction in allergic consumers.

  • Action required

    Do not eat the product if you or someone in your household has a diagnosed allergy. Check the codes below, return it to the retailer for a refund, or dispose of it safely. Seek urgent care for signs of a severe allergic reaction.

Recall closed · classified by the FDACA, FL, GA, IL +6 moreMore food

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Share via WhatsApp

Match before you discard

Product identification

Source: FDA FOOD

Brand nameMiami Interculinary Center, INC.
Recalling firmMiami Interculinary Center, INC.Miami, FL, United States
UPC / barcodesNo UPC listed in the FDA enforcement record.
Lot / date codes
  • Lot # 07171311
Distribution area
CAFLGAILMDNCOHPAVAWA

CA, FL, GA, IL, MD, NC, OH, PA, VA, and WA

United States

Quantity affected1, 164 bottles
Recall initiationFDA report date: July 2, 2014
FDA recall numberF-2030-2014

Beyond the headline

The recall, in context

Miami Interculinary Center, INC. initiated this food recall on April 23, 2014. The FDA enforcement report states: During an FDA inspection a product was found that the label fail to declared the component ingredients of all its compound ingredients like Mayonnaise and Worcestershire sauce that contains allergens like eggs, soy, and anchovies. The FDA report lists distribution as: CA, FL, GA, IL, MD, NC, OH, PA, VA, and WA.

The FDA enforcement report describes the reason as: During an FDA inspection a product was found that the label fail to declared the component ingredients of all its compound ingredients like Mayonnaise and Worcestershire sauce that contains allergens like eggs, soy, and anchovies.

Floribbean Key Lime Calypso Dip 12.5 OZ Floribbean 68 Sw 40 St was made or distributed by Miami Interculinary Center, INC. in Miami, FL, United States. This page reflects FDA report F-2030-2014, dated July 2, 2014.

Why this is a Class I recall

Class I means the product has a reasonable probability of causing serious adverse health consequences or death. In this recall, an allergen that is present but missing or incorrect on the label can cause a serious reaction in allergic consumers.

FDA definition

The product has a reasonable probability of causing serious adverse health consequences or death.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the lot and date codes against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Undeclared soy

Symptoms to watch for

Hives, swelling, wheezing, vomiting or anaphylaxis can occur in people with a soy allergy.

When symptoms may appear

Reactions can begin within minutes to a few hours after eating the product.

Higher-risk groups

People with a diagnosed soy allergy, especially children and anyone with a history of anaphylaxis.

What to do now

  1. 1Do not eat the product if you have a soy allergy.
  2. 2Seek emergency care for breathing difficulty, throat swelling or other signs of anaphylaxis.
  3. 3Keep the packaging and contact the retailer or manufacturer about a refund.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Floribbean Key Lime Calypso Dip 12.5 OZ Floribbean 68 Sw 40 St recall?

Miami Interculinary Center, INC. recalled Floribbean Key Lime Calypso Dip 12.5 OZ Floribbean 68 Sw 40 St in an FDA Class I enforcement action reported as F-2030-2014. During an FDA inspection a product was found that the label fail to declared the component ingredients of all its compound ingredients like Mayonnaise and Worcestershire sauce…

What should I do if I bought this product?

Do not eat the product if you or someone in your household has a diagnosed allergy. Check the codes below, return it to the retailer for a refund, or dispose of it safely. Seek urgent care for signs of a severe allergic reaction. Do not eat the product if you have a soy allergy. Seek emergency care for breathing difficulty, throat swelling or other signs of anaphylaxis. Keep the packaging and contact the retailer or manufacturer about a refund.

Is the Miami Interculinary Center, INC. recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-2030-2014. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Related alerts

Recent Undeclared allergens recalls

All alerts
Class I·

Oliva on Main

Riad's Oliva to Go Spicy Baba Ghanouj

Contains undeclared sesame

MA, CTFood
Class I·

Oliva on Main

Riad's Oliva to Go Baba Ghanouj

Contains undeclared sesame

MA, CTFood

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.